Related Experiment Video
Updated: Jul 11, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
[Gastro Intestinal Stromal Tumor--clinical and pathological presentation]
Michael Bau Mortensen1, Knud Erik Larsen, Claus Wilki Fristrup
1Odense Universitetshospital, Øvre GI-sektion, Kirurgisk Afdeling A. m.bau@dadlnet.dk
This study analyzed 41 gastrointestinal stromal tumor (GIST) cases in Denmark, finding their clinical presentation and treatment outcomes align with global data. Early detection and surgical resection are key for managing this rare cancer.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Context:
- Gastrointestinal stromal tumors (GIST) are rare mesenchymal neoplasms.
- KIT tyrosine kinase is a key diagnostic marker for GIST.
- Surgical resection is the primary treatment for localized GIST.
Purpose:
- To evaluate the clinical and pathological characteristics of a Danish GIST patient cohort.
- To compare the presentation and management of GIST in Denmark with international findings.
Summary:
- A retrospective study identified 41 GIST patients (median age 62) between 1995-2006.
- Predominant symptoms included gastrointestinal bleeding and abdominal pain; most tumors were in the stomach or small intestine.
- Complete surgical resection was achieved in 95% of patients; approximately two-thirds had low/medium metastatic risk, and 25% received tyrosine kinase inhibitors.
Impact:
- Findings suggest increasing GIST detection rates due to improved immunostaining.
- The clinical and pathological profile of Danish GIST patients is consistent with international data.
- This study contributes to understanding GIST epidemiology and management in a specific national population.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Inflammatory Bowel Disease IV: Clinical Manifestations
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...